- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced or Metastatic Non-small Cell Lung Cancer in Germany
Total 640 results
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Eli Lilly and CompanyCompleted
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung CancerSpain, Italy, Poland, Brazil, Turkey, Serbia, France, Korea, Republic of, Romania, Hungary, Russian Federation, United States, United Kingdom, Germany, Greece, Japan, Thailand, Ukraine, China
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
Astellas Pharma IncCompletedLung Cancer | Carcinoma, Non-Small Cell Lung | Cancer of Lung | Non-Small Cell Lung Carcinoma | Cancer of the LungGermany, Czech Republic, Netherlands
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Germany, Portugal
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Spain, United Kingdom, Germany, Italy, Poland, France
-
AstraZenecaCompletedNon-small Cell Lung Cancer (NSCLC)United Kingdom, United States, Italy, Spain, France, Germany
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, Italy, France, Germany
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerItaly, United States, Germany, Poland, Belgium, United Kingdom
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IVGeorgia, India, Romania, Spain, Germany, Japan, Malaysia
-
Boehringer IngelheimUniversitätsklinikum Kiel, Onkologisches ZentrumRecruitingColorectal Cancer | Pancreatic Ductal Adenocarcinoma | Non-Small-Cell Lung CarcinomaGermany
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
University of CologneCharite University, Berlin, Germany; University Hospital, Essen; University Medicine... and other collaboratorsActive, not recruitingNon-small Cell Lung Cancer Stage IVGermany
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerGermany, Austria, France
-
Aktion Bronchialkarzinom e.V.CompletedNon-Small-Cell Lung CarcinomaGermany
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerFrance, Spain, United States, Belgium, Netherlands, Canada, Italy, Singapore, Korea, Republic of, Czechia, Germany, Hong Kong
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
Geron CorporationCompletedNon-small Cell Lung CancerUnited States, Canada, Germany
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, HellasCompletedNon-small Cell Lung Cancer Stage IIISwitzerland, Netherlands, Spain, Belgium, Germany
-
Incyte CorporationCompletedNon-Small Cell Lung Cancer (NSCLC)Spain, United States, Italy, Germany, France
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, France, Germany, Russian Federation, Poland, Italy
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
PfizerCompletedHepatocellular Carcinoma | Advanced Breast Cancer | Non-Small Cell Lung Cancer | Metastatic Breast Cancer | Metastatic Renal Cell Cancer | Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Gastrointestinal Stromal Tumor | Advanced Gastric Cancer | Metastatic Castration Resistant Prostate Cancer | Advanced... and other conditionsUnited States, Spain, Korea, Republic of, France, Australia, United Kingdom, Canada, Brazil, Argentina, Taiwan, Belgium, Colombia, Germany, Hong Kong, Mexico, Philippines, Singapore
-
Ariad PharmaceuticalsCompletedCarcinoma | Lung Cancer | Non-small Cell Lung Cancer | Advanced MalignanciesUnited States, Canada, Germany, Spain, Taiwan, Korea, Republic of, Switzerland, Hong Kong, Singapore, Italy, Sweden, United Kingdom, France, Netherlands, Denmark, Australia, Norway, Austria, Luxembourg
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerChina, Taiwan, Belgium, Netherlands, Spain, Germany, Singapore, Italy, Japan, Australia, Israel, Korea, Republic of, Thailand, France
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHCompleted
-
AbbVieActive, not recruitingNon Small Cell Lung CancerUnited States, Australia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Taiwan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
ETOP IBCSG Partners FoundationEuropean Organisation for Research and Treatment of Cancer - EORTC; AmgenTerminatedLung Cancer Non-small Cell Stage IVIreland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland
-
Technische Universität DresdenRadiation Oncology Working Group of the German Cancer Society; German Consortium... and other collaboratorsCompletedPostoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional FractionationNon-Small Cell Lung CancerGermany, Poland
-
AstraZenecaParexelWithdrawnNon Small Cell Lung CancerItaly, Russian Federation, Spain, China, Netherlands, United States, Taiwan, France, Germany
-
Hoffmann-La RocheRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Canada, Turkey, Brazil, Spain, France, Germany, Australia, Italy, Belgium, Mexico
-
Threshold PharmaceuticalsEMD SeronoTerminatedNon-small Cell Lung CancerUnited States, Germany, Spain, Poland, Greece, Czechia, Hungary, Italy, Romania, Russian Federation
-
European Organisation for Research and Treatment...TerminatedLung CancerBelgium, Netherlands, Germany, Poland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
University of CologneCompleted
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines